Metastatic Neuroendocrine Tumors

Also known as: Metastatic Neuroendocrine Tumor

Drug	Drug Name	Drug Description
DB01101	Capecitabine	A nucleoside metabolic inhibitor indicated to treat different gastrointestinal, including pancreatic cancer, and breast cancer.

Drug	Drug Name	Target	Type
DB01101	Capecitabine	Thymidylate synthase	target
DB01101	Capecitabine	Thymidine phosphorylase	enzyme
DB01101	Capecitabine	Cytidine deaminase	enzyme
DB01101	Capecitabine	Liver carboxylesterase 1	enzyme
DB01101	Capecitabine	Cytochrome P450 2C9	enzyme
DB01101	Capecitabine	DNA	target
DB01101	Capecitabine	RNA	target
DB01101	Capecitabine	Serum albumin	carrier
DB01101	Capecitabine	Uridine phosphorylase 1	enzyme
DB01101	Capecitabine	Uridine phosphorylase 2	enzyme

Drug	Drug Name	Phase	Status	Count
DB13985	Lutetium Lu 177 dotatate	1	Active Not Recruiting	1
DB11940	Triapine	1	Active Not Recruiting	1
DB11840	Dalotuzumab	2	Completed	1
DB14844	Dordaviprone	2	Completed	1
DB13985	Lutetium Lu 177 dotatate	2	Recruiting	1
DB11940	Triapine	2	Recruiting	1
DB04879	Vatalanib	2	Completed	1